Okabena Investment Services Inc. Has $658,000 Stock Position in The Clorox Company (NYSE:CLX)

Okabena Investment Services Inc. lessened its stake in shares of The Clorox Company (NYSE:CLX - Free Report) by 42.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 4,050 shares of the company's stock after selling 3,041 shares during the period. Okabena Investment Services Inc.'s holdings in Clorox were worth $658,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the stock. Thrivent Financial for Lutherans raised its holdings in Clorox by 2.7% during the 3rd quarter. Thrivent Financial for Lutherans now owns 9,091 shares of the company's stock worth $1,481,000 after buying an additional 236 shares during the period. FMR LLC raised its holdings in shares of Clorox by 27.6% during the third quarter. FMR LLC now owns 776,232 shares of the company's stock valued at $126,456,000 after acquiring an additional 168,111 shares during the period. Townsquare Capital LLC purchased a new stake in shares of Clorox in the 3rd quarter valued at approximately $363,000. CreativeOne Wealth LLC acquired a new position in Clorox in the 3rd quarter worth approximately $213,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in Clorox by 2.6% during the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 49,468 shares of the company's stock worth $8,059,000 after purchasing an additional 1,247 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Stock Down 0.9 %

Shares of CLX stock traded down $1.31 on Wednesday, hitting $146.60. The company's stock had a trading volume of 296,083 shares, compared to its average volume of 1,440,333. The stock has a market capitalization of $18.06 billion, a price-to-earnings ratio of 40.05, a P/E/G ratio of 2.62 and a beta of 0.45. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The firm's fifty day moving average price is $150.83 and its 200-day moving average price is $158.74. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the company earned $2.16 earnings per share. Research analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.33%. Clorox's payout ratio is presently 133.33%.

Analyst Ratings Changes

Several analysts have recently commented on CLX shares. Barclays decreased their target price on Clorox from $140.00 to $139.00 and set an "underweight" rating for the company in a research report on Thursday, March 27th. Wells Fargo & Company decreased their price objective on Clorox from $161.00 to $155.00 and set an "equal weight" rating for the company in a research report on Wednesday. StockNews.com downgraded Clorox from a "buy" rating to a "hold" rating in a report on Sunday, January 5th. Royal Bank of Canada restated a "sector perform" rating and set a $150.00 price target on shares of Clorox in a report on Thursday, January 30th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $171.00 to $173.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. Three analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Hold" and a consensus price target of $159.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.